Mar 28,2018

Bigfoot Biomedical closes Series B financing round with $55M

A diabetes startup that uses artificial intelligence, Bigfoot Biomedical, has just announced that it scored a total of $55 million in Series B equity financing with new investments from Abbott and other existing funders.

FUNDING SERIES B
View Analyst & Ambassador Comments
Go to original news
Apr 04,2018

Virta Health Raises $45 Million to Expand Treatment for Type 2 Diabetes Reversal

Virta Health, the first company with a clinically-proven treatment to safely and sustainably reverse type 2 diabetes (T2D) and other chronic metabolic diseases without the use of medications or surgery, announced it has raised a $45 million Series B funding round, bringing the total equity funding to $75 million to date. Key existing investors including Venrock, Obvious Ventures, Creandum, Caffeinated Capital, and Max Levchin’s SciFi VC participated in the round, along with new investors including Founders Fund and Playground Global.

FUNDING SERIES B
View Analyst & Ambassador Comments
Go to original news
Jul 12,2017

With $18.3M in new funding, Solera Health looks beyond diabetes prevention

Solera Health, the Phoenix-based company that has created a marketplace for digital and in-person diabetes prevention programs, has raised $18.3 million in a round led by Adams Street Partners, with additional participation from Blue Cross Blue Shield Venture Partners, Sandbox Industries and SJF Ventures. The round, Solera's largest to date, brings its total funding to $30.3 million.

FUNDING SERIES B
View Analyst & Ambassador Comments
Go to original news
Aug 23,2017

DarioHealth Closes on $5 Million Through Private Placement Offerings

DarioHealth Corp. (NASDAQ: DRIO), a leading global digital health Company with mobile health and big data solutions, announced today that it has closed on concurrent private placement offerings with domestic and non-U.S. investors for the sale of shares of the Company's common stock and shares of the Company's newly designated Series B Convertible Preferred Stock in concurrent private placement offerings. As a part of these private placement transactions, which totals $5 million in the aggregate before expenses and placement agent fees, the Company issued 483,333 shares of common stock at a price per share of $1.80 and 2,307,654 shares of Series B Convertible Preferred Stock at a price per share of $1.80. Investors in the offering included existing investors, as well as new investors including SC Fundamental Value Fund, L.P. and Pegasus Capital II, L.P.

FUNDING SERIES B
View Analyst & Ambassador Comments
Go to original news
Dec 18,2017

Bigfoot Biomedical's automated insulin delivery systems attract $37M in Series B funding

Milpitas, California-based diabetes management device maker Bigfoot Biomedical has raised $37 million in Series B funding in a round co-led by funds from Janus Henderson Investors and Quadrant Capital Advisors. Additional participants included Cormorant Asset Management, Senvest Capital Inc., Senvest Management LLC, Visionnaire Ventures, JDRF T1D Fund, and T1D Exchange.

FUNDING SERIES B
View Analyst & Ambassador Comments
Go to original news
Dec 05,2017

Health2Sync lands $6 million in Series B funding for Japanese expansion

Diabetes management company Health2Sync is looking to expand its operation into Japan after raising $6 million in Series B investments led by Sompo Holdings, one of Japan’s largest insurance companies.

FUNDING SERIES B
View Analyst & Ambassador Comments
Go to original news
Jan 04,2016

Robert Bosch Venture Capital leads $3.1M round in digital diabetes startup

Germany-based digital health startup Emperra has raised $3.1 million in a round led by Robert Bosch Venture Capital with participation from existing investors, Peppermint VenturePartners and Investitionsbank des Landes Brandenburg. Emperra offers a digital diabetes management system that includes connected health devices and software. The company's executives also contributed to the round. Emperra's primary product, Esysta, includes smart insulin pens, wireless-enabled blood glucose meters, and CE-marked software that runs on various platforms including smart TVs, web portals, and mobile apps.

FUNDING SERIES B
View Analyst & Ambassador Comments
Go to original news
Dec 08,2016

Vida Health, the app that pairs patients with health coaches, nabs $18 million more from investors

Vida Health, a two-year-old, Palo Alto, Ca.-based subscription-based app that pairs patients with health coaches, has raised $18 million in Series B funding led by Canvas Ventures, with participation from Nokia Growth and earlier backers Aspect Ventures and Khosla Ventures.

FUNDING SERIES B
View Analyst & Ambassador Comments
Go to original news
Mar 17,2015

Glooko gets $16.5 million from Canaan Partners, Medtronic

Diabetes management platform Glooko has raised $16.5 million in a round led by Canaan Partners. The round also included a strategic investment from Medtronic as well as funding from additional investors The Social+Capital Partnership and Samsung.

FUNDING SERIES B
View Analyst & Ambassador Comments
Go to original news
Apr 07,2015

Tullman's diabetes startup Livongo picks up $20M from Kleiner, DFJ

Livongo Health, the diabetes management company launched last fall by former Allscripts CEO Glen Tullman, has raised $20 million in second-round funding. Kleiner Perkins Caufield & Byers (KPCB) and DFJ Venture contributed to the round, as did previous investor General Catalyst Partners.

FUNDING SERIES B
View Analyst & Ambassador Comments
Go to original news
Subscribe to SERIES B